Clinical Trial Update: BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov update reports that a Phase 1 study of BTX-A51 is currently recruiting for liposarcoma and CIC-rearranged sarcoma, including myxoid lipo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cic-rearranged Sarcoma
• Liposarcoma
• Myxoid Liposarcoma

Drugs mentioned

• BTX-A51

Snippet

Sponsor: Michael Wagner, MD | Conditions: Liposarcoma, Recurrent Liposarcoma | Phase 1 | Status: RECRUITING